Tool overview
Enjamb is listed under AI for Science AI tools.
What is Enjamb?
Enjamb is an agentic workspace for pharmaceutical and life-science teams. It unifies evidence synthesis, experimental planning, statistical programming, regulatory writing, files, compute, and collaboration across a drug program.
Best for
Life-science teams coordinating evidence, analysis, and regulatory deliverables
Who is it for?
Decision note
Suitable for evaluation after confirming final commercial terms, permissions, data handling, current product scope, and edit-screen aliases. Keep Needs Review enabled until a human verifies the published profile.
Key features
Literature review across large scientific corpora
Clinical evidence synthesis and protocol planning
Sandboxed Python and R statistical analysis
Regulatory writing and submission support
Shared files, projects, storage, and team roles
Use cases
Review evidence for a drug program
Design and document research methods
Run biostatistical analysis and figures
Prepare regulatory and scientific materials
Pros
- Covers multiple stages of drug development
- Combines scientific files with executable analysis
- Publishes transparent self-service pricing
Cons
- Scientific outputs require expert validation
- Enterprise integrations may need implementation work
Limitations
Enjamb can accelerate scientific and regulatory work but does not replace qualified researchers, biostatisticians, clinicians, quality teams, or regulatory professionals. Validate methods, citations, code, figures, and submission-critical content before use.
Pricing details
Billing options
Pricing note
The official pricing page lists a continuing Free plan, Pro at $20 per month billed annually, Max at $40 per month billed annually, Lab at $40 per seat per month billed annually, and custom Enterprise terms. No separate public free trial is listed.
Supported languages
- English
Integrations
Benchling
Veeva
Medidata
SAS
Zotero
GitHub
Please log in to join the discussion.